Target Nuclear Factor Erythroid 2-Related Factor 2 in Pulmonary Hypertension: Molecular Insight into Application

Oxid Med Cell Longev. 2022 Jun 6:2022:7845503. doi: 10.1155/2022/7845503. eCollection 2022.

Abstract

Nuclear factor erythroid 2-related factor 2 (Nrf2) is a key transcription factor involved in maintaining redox balance and activates the expression of downstream antioxidant enzymes. Nrf2 has received wide attention considering its crucial role in oxidative and electrophilic stress. Large amounts of studies have demonstrated the protective role of Nrf2 activation in various pulmonary hypertension (pH) models. Additionally, various kinds of natural phytochemicals acting as Nrf2 activators prevent the development of pH and provide a novel and promising therapeutic insight for the treatment of pH. In the current review, we give a brief introduction of Nrf2 and focus on the role and mechanism of Nrf2 in the pathophysiology of pH and then review the relevant research of Nrf2 agonists in pH in both experimental research and clinical trials.

Publication types

  • Review

MeSH terms

  • Antioxidants / metabolism
  • Humans
  • Hypertension, Pulmonary* / drug therapy
  • NF-E2-Related Factor 2* / metabolism
  • Oxidation-Reduction
  • Oxidative Stress / physiology

Substances

  • Antioxidants
  • NF-E2-Related Factor 2